未知生产厂商
Satraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
Satraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
This drug binds to the DNA of cancer cells, inhibiting cell division.
Investigated for use/treatment in lung cancer, prostate cancer, and solid tumors.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
